Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Payables (2019 - 2024)

Historic Payables for Cresco Labs (CRLBF) over the last 6 years, with Q4 2024 value amounting to $11.9 million.

  • Cresco Labs' Payables fell 6971.37% to $11.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.9 million, marking a year-over-year decrease of 6971.37%. This contributed to the annual value of $11.9 million for FY2024, which is 6971.37% down from last year.
  • According to the latest figures from Q4 2024, Cresco Labs' Payables is $11.9 million, which was down 6971.37% from $19.2 million recorded in Q3 2024.
  • Cresco Labs' 5-year Payables high stood at $39.4 million for Q4 2023, and its period low was -$9.8 million during Q1 2020.
  • Moreover, its 5-year median value for Payables was $13.5 million (2021), whereas its average is $13.8 million.
  • Per our database at Business Quant, Cresco Labs' Payables crashed by 11039.09% in 2020 and then soared by 814795.92% in 2023.
  • Cresco Labs' Payables (Quarter) stood at -$6.5 million in 2020, then skyrocketed by 249.95% to $9.8 million in 2021, then surged by 49.97% to $14.7 million in 2022, then skyrocketed by 168.38% to $39.4 million in 2023, then tumbled by 69.71% to $11.9 million in 2024.
  • Its last three reported values are $11.9 million in Q4 2024, $19.2 million for Q3 2024, and $18.8 million during Q2 2024.